Pfizer Inc. (PFE)
| Previous Close | 41.47 |
| Open | 41.46 |
| Bid | 41.74 x 1800 |
| Ask | 41.80 x 3000 |
| Day's Range | 41.42 - 41.83 |
| 52 Week Range | 32.83 - 43.08 |
| Volume | 21,609,212 |
| Avg. Volume | 25,005,287 |
| Market Cap | 233.312B |
| Beta (5Y Monthly) | 0.67 |
| PE Ratio (TTM) | 21.11 |
| EPS (TTM) | 1.97 |
| Earnings Date | Jul. 26, 2021 - Jul. 30, 2021 |
| Forward Dividend & Yield | 1.56 (3.98%) |
| Ex-Dividend Date | Jul. 29, 2021 |
| 1y Target Est | 42.97 |
- Reuters
S.Korea starts vaccination for 55-59 age group as COVID-19 caseloads remain high
South Korea kicked off COVID-19 vaccinations for people ages 55-59 on Monday to speed up the pace of its inoculation campaign, as the country battles the fourth wave of infections. The rollout of COVID-19 vaccinations for people in their upper 50s had sputtered to a week-long halt this month after a record high number of new cases sparked a rush for shots, exhausting available supplies and crashing an official reservation website.. About 6.17 million people, or 84% of those in their 50s, have signed up for vaccinations last week, and authorities switched to Pfizer/BioNTech's COVID-19 vaccine from Moderna shot for some people in the group because of fluctuations in shipment schedule.
- Motley Fool
3 Value Stocks to Buy for the Second Half of 2021
Here are three value stocks to buy for the second half of 2021. With such a low valuation relative to its peers, you might think that AbbVie would be struggling. The company's revenue grew 51% year over year in the first quarter of 2021.
- Motley Fool
This News May Hand the Vaccine Market Over to Pfizer and Moderna
It's fair to say that Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are dominating the coronavirus vaccine market these days. Their vaccines have fully immunized 86 million and 62 million Americans, respectively.
